Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Teng Aik Ong is a leading urological oncologist whose research has fundamentally shaped the understanding of prostate cancer disparities across Asia. As a principal investigator of the landmark Asian Prostate Cancer (A-CaP) study, Dr. Ong spearheaded a continent-wide initiative launched in 2015 to systematically analyze clinical and pathological data from thousands of patients. His seminal work, including the highly cited "Report of the third Asian Prostate Cancer study meeting" (2018, 12 citations), has been instrumental in clarifying how genetic, environmental, and lifestyle factors drive distinct disease distributions and treatment outcomes among Asian populations. By establishing robust multicenter registries and standardized data collection protocols, Dr. Ong’s contributions have enabled clinicians to move beyond Western-centric models, tailoring screening and therapeutic strategies to regional needs. His leadership in the A-CaP consortium has not only generated critical insights into prostate cancer epidemiology but also fostered unprecedented international collaboration, directly impacting clinical guidelines and patient care across Asia. Dr. Ong’s dedication to bridging research and practice continues to inspire a new generation of oncologists working toward precision medicine in diverse populations.